Insider · CIK 0001329505
Gregory Bailey
Files at SER (Serina Therapeutics, Inc.), BHVN (Biohaven Ltd.). First filing Dec 19, 2024, latest Nov 17, 2025.
In brief
Gregory Bailey files SEC Form 4 as director at SER (Serina Therapeutics, Inc.), and also at BHVN (Biohaven Ltd.). Since Dec 19, 2024, Gregory Bailey has reported 2 open-market buys worth $3.0M and 0 open-market sells worth $0, the latest filed on Nov 17, 2025.
A track record needs three past buys with six months of prices behind them; Gregory Bailey has 0, so none is measured yet.
The newest scored trade: bought $3.0M of BHVN on Nov 13, 2025, filed Nov 17, 2025, scored 79 (notable). In the last 12 months: 1 buy worth $3.0M and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
BHVN: Biohaven Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
SER: Serina Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 79Notable | Biohaven Ltd. | $3.0M 400,000 shares | +25% | +4% from low-84% from high | |
| 18Weak | SERbuy Serina Therapeutics, Inc. | $18k 3,866 shares | +6% | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | CConversion Common Stock | +1,770,805 | $2.25 | $4.0M | 1,897,445 | Jun 22, 2026 |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | CConversion Common Stock | +6,666,667 | $2.25 | $15M | 8,564,382 | Jun 22, 2026 |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,250 | $0.00 | $0 | 15,250 | Jun 22, 2026 |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Redeemable Warrantsderivative | +3,333,333 | $0.00 | $0 | 3,333,333 | Jun 22, 2026 |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | CConversion Series A Convertible Preferred Stockderivative | -762,548 | $2.25 | $1.7M | 0 | Jun 22, 2026 |
| Apr 28, 2026 | BHVN Biohaven Ltd. | AGrant or award Stock Options (Right to buy)derivative | +68,693 | $0.00 | $0 | 68,693 | Apr 30, 2026 |
| Mar 31, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Common Stock | +59,667 | $1.94 | $116k | 126,910 | Apr 21, 2026 |
| Nov 13, 2025 | BHVN Biohaven Ltd. | POpen-market purchase Common Shares | +400,000 | $7.50 | $3.0M | 2,020,071 | Nov 17, 2025 |
| Nov 7, 2025 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Nov 10, 2025 |
| May 5, 2025 | BHVN Biohaven Ltd. | AGrant or award Stock Options (Right to buy)derivative | +31,716 | $0.00 | $0 | 31,716 | May 7, 2025 |
| Apr 8, 2025 | SER Serina Therapeutics, Inc. | AGrant or award Series A Convertible Preferred Stockderivative | +762,548 | $5.18 | $3.9M | 762,548 | Apr 10, 2025 |
| Dec 17, 2024 | SER Serina Therapeutics, Inc. | POpen-market purchase Common Stock | +3,866 | $4.59 | $18k | 67,243 | Dec 19, 2024 |
Questions about Gregory Bailey
Answered from the filings on this page, as of the latest one.
Is Gregory Bailey buying or selling?
In the last 12 months Gregory Bailey reported 1 open-market buy worth $3.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $3.0M of BHVN on Nov 13, 2025. Grants, option exercises and tax withholding are not counted.
How did Gregory Bailey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory Bailey has 0.
Where does Gregory Bailey file Form 4?
Gregory Bailey has filed Form 4 at SER (Serina Therapeutics, Inc.); BHVN (Biohaven Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.